Dechra Pharmaceuticals PLC is an England-based business involved in the development and marketing of veterinary products. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Dechra Pharmaceuticals PLC is an England-based business involved in the development and marketing of veterinary products. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Dechra Pharmaceuticals plc (LON:DPH) has announced that after 12 years’ service with Dechra, Tony Griffin will step down as an...
The Board of The Baillie Gifford Japan Trust PLC (LON:BGFD) has announced the appointment of Patricia Lewis as a non-executive...
Dechra Pharmaceuticals PLC (LON:DPH) has issued today the following unaudited trading update in respect of the financial year ending 30...
Dechra Pharmaceuticals plc (LON:DPH) has issued the following statement prior to the Annual General Meeting (AGM) which will take place...
Dechra Pharmaceuticals PLC (LON:CPH) has issued its audited preliminary results for the year ended 30 June 2022. “We have continued...
Dechra Pharmaceuticals plc (LON:DPH) has announced it has acquired Med-Pharmex, Inc. Med-Pharmex is a leading veterinary pharmaceutical manufacturer based in...
Dechra Pharmaceuticals plc (LON:CPH) has issued the following unaudited Trading Update covering the Group’s financial year ended 30 June 2022...
Dechra Pharmaceutical plc (LON:DPH) has announced that the acquisition of the worldwide rights of the Osurnia product portfolio from Elanco...
Dechra Pharmaceuticals plc (LON:DPH) has today announced that it has agreed terms to acquire the worldwide rights to the Mirataz®...
Dechra Pharmaceuticals plc (LON:DPH) has today announced that, with effect from 1 March 2020, Alison Platt will take up a...
Dechra Pharmaceuticals (LON: DPH) has issued the following unaudited Trading Update covering the half year reporting period from 1 July...
Dechra Pharmaceuticals plc (LON: DPH) has announced that it has agreed terms to acquire the worldwide rights to the Osurnia...
Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.